Life Sciences
Intellectual Property

Overview


Protect. Grow. Flourish. 

As a life sciences company, your intellectual property is your most valuable asset—it’s what propels your growth, drives your success and sets you apart from competitors. But it may also be your most vulnerable asset.

How you commercialize your innovation and gain compliance is crucial for the success of your business. As competitors constantly work to capture your share of the market, it is imperative that your IP is protected to maximize its value.

Show More

Results


  • Novartis Vaccines, the pharmaceutical company’s division that provides more than 20 products to fight vaccine-preventable viral and bacterial disease, in obtaining summary judgment. We served as lead counsel for the case, which was an action under 28 USC 146 for district court review of an interference decision by the Board of Patent and Trademark Appeals. AlphaVax, Inc. v. Novartis Vaccines and Diagnostics, Inc., Case No. 1-09-cv-11176 (District of Massachusetts).
  • Ambry Genetics in its successful defense against a 16-patent suit and a preliminary injunction, which led to the subsequent defeat of Myriad Genetics’ 15-year patent-protected monopoly on BRCA gene testing, a process that assesses a woman’s risk of developing breast or ovarian cancer. University of Utah Research Foundation et al. v. Ambry Genetics Corporation, Case No. 2-13-cv-00640-RJS (District of Utah). Six of those patents to stop Ambry resulted in a Federal Circuit opinion, In Re Brca1- and Brca2-Based Hereditary Cancer Test Patent Litigation.
  • Seikagaku Corporation and Zimmer in securing a verdict of non-infringement on all asserted claims in a case filed by Genzyme Corporation. Genzyme filed a lawsuit against Seikagaku and Zimmer alleging that Seikagaku’s product, Gel-One®, distributed by Zimmer, infringed Genzyme’s patent related to the method of using a single injection of hyaluronic acid to treat osteoarthritis of the knee. Genzyme Corp. v. Seikagaku Corp., et al., Case No. 1-11-cv-10636-DPW (District of Massachusetts).

Show More

People


We provide a full array of legal services to help you take your IP further.

Life Sciences
Intellectual Property

Insights & Events / Media

Cambridge, MA / McDermott Event / October 15-16 2019

IP Update / July 2019

On the Subject / July 12, 2019

IP Update / June 2019

IP Update / May 2019

IP Update / April 2019

IP Update / March 2019

IP Update / December 2018

IP Update / November 2018

IP Update / October 2018

IP Update / September 2018

IP Update / August 2018

Boston, Massachusetts / Speaking Engagements / August 20, 2018

IP Update / July 2018

/ July 2018

IP Update / June 2018

On the Subject / June 15, 2018

Copenhagen, Denmark / Speaking Engagements / June 11, 2018

IP Update / May 2018

Princeton, New Jersey / Speaking Engagements / May 6, 2018

Boston, Massachusetts / Speaking Engagements / May 3, 2018

Boston, Massachusetts / Speaking Engagements / April 26, 2018

IP Update / April 2018

IP Update / March 2018

China / / March 2018

AHLA (American Health Lawyers Association) / March 2018

Special Report / March 2018

IP Update / February 2018

Stanford, California / Speaking Engagements / February 14, 2018

Burlington, Massachusetts / McDermott Event / February 13, 2018

IP Update / January 2018

Special Report / January 11, 2018

IP Update / December 2017

IP Update / November 2017

/ November 2017

Cambridge, Massachusetts / McDermott Event / October 4, 2017

IP Update / August 2017

IP Update / July 2017

/ July 2017

IP Update / June 2017

IP Update / March 2017

/ March 2017

IP Update / February 2017

Costa Mesa, California / McDermott Event / January 31, 2017

Chicago, Illinois / McDermott Event / January 31, 2017

Special Report / January 31, 2017

Menlo Park, California / McDermott Event / January 26, 2017

IP Update / January 2017

Burlington, Massachusetts / McDermott Event / January 17, 2017

IP Update / December 2016

1

2

3

4

5

6

7

8

9

10

... 10